Jw Life Science Corp (234080) — Financial Flexibility Index
Jw Life Science Corp (234080) has a Financial Flexibility Index of 0.10x as of December 2025. Free cash flow of ₩9.35 Billion (operating CF ₩5.08 Billion minus capex ₩4.27 Billion) represents 0% of total liabilities (₩97.63 Billion). Also explore 234080 net assets growth trend to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Jw Life Science Corp Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for Jw Life Science Corp across 11 annual periods. Check 234080 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Jw Life Science Corp (2015–2025)
Year-by-year free cash flow to debt coverage for Jw Life Science Corp. For the full company profile including market capitalisation, see Jw Life Science Corp (234080) total market value.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.55x | ₩53.97 Billion | ₩40.54 Billion | ₩97.63 Billion | ▲ +13.2% |
| 2024 | 0.49x | ₩61.00 Billion | ₩50.69 Billion | ₩124.88 Billion | ▲ +2.8% |
| 2023 | 0.48x | ₩45.84 Billion | ₩37.57 Billion | ₩96.44 Billion | ▲ +138.7% |
| 2022 | 0.20x | ₩22.42 Billion | ₩14.13 Billion | ₩112.61 Billion | ▼ -64.4% |
| 2021 | 0.56x | ₩49.14 Billion | ₩30.17 Billion | ₩87.97 Billion | ▼ -23.4% |
| 2020 | 0.73x | ₩62.69 Billion | ₩46.75 Billion | ₩85.98 Billion | ▲ +77.5% |
| 2019 | 0.41x | ₩32.37 Billion | ₩24.28 Billion | ₩78.79 Billion | ▼ -18.5% |
| 2018 | 0.50x | ₩46.17 Billion | ₩36.13 Billion | ₩91.60 Billion | ▲ +57.7% |
| 2017 | 0.32x | ₩30.82 Billion | ₩22.05 Billion | ₩96.43 Billion | ▲ +10.6% |
| 2016 | 0.29x | ₩29.45 Billion | ₩16.08 Billion | ₩101.94 Billion | ▼ -42.8% |
| 2015 | 0.51x | ₩49.03 Billion | ₩25.90 Billion | ₩97.05 Billion | — |